Carbon monoxide-induced early thrombolysis contributes to heme oxygenase-1-mediated inhibition of neointimal growth after vascular injury in hypercholesterolemic mice

Journal of Biomedical Science

Volumn 13, Issue 5, 2006, Pages 721-730

  Chen, Yen Hui ^a   Tsai, Hui Ling ^a   Chiang, Ming Tsai ^a   Chau, Lee Young ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Heme oxygenase; Thrombolysis; Vascular injury

Indexed keywords

ADENOVIRUS VECTOR; CARBON MONOXIDE; HEME OXYGENASE 1;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL INJURY; CELL INFILTRATION; CONTROLLED STUDY; GENE THERAPY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOLIPOPROTEINS E; CARBON MONOXIDE; CAROTID ARTERY, COMMON; FIBRIN; FIBRINOGEN; HEME OXYGENASE-1; HYPERCHOLESTEROLEMIA; INFLAMMATION; MALE; MICE; MUSCLE DEVELOPMENT; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSIS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA;

EID: 33749361935     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-006-9093-7     Document Type: Article

References (30)

1. Otterbein L.E. and Choi A.M.K., Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. 279: L1029-1037, 2000.
2. Aizawa T., Ishizaka N., Taguchi J., Kimura S., Kurokawa K. and Ohno M., Balloon injury does not induce heme oxygenase-1 expression, but administration of hemin inhibits neointimal formation in balloon-injured rat carotid artery. Biochem. Biophys. Res. Commun. 261: 302-307, 1999.
3. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., Clinton Webb R., Lee M.E., Nabel G.J. and Nabel E.G., Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7: 693-698, 2001.
4. Juan S.H., Lee T.S., Tseng K.W., Liou J.Y., Shyue S.K., Wu K.K. and Chau L.Y., Adenovirus-mediated heme oxygenase gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525, 2001.
5. Togane Y., Morita T., Suematsu M., Ishimura Y., Yamazaki J.I. and Katayama S., Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am. J. Physiol. Heart Circ. Physiol. 278: H623-H632, 2000.
6. Ishikawa K., Navab M., Leitinger N., Folelman A.M. and Lusis A.J., Inhibition of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J. Clin. Invest. 100: 1209-1216, 1997.
7. Brune B. and Ullrich V., Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol. Pharmacol. 32: 497-504, 1987.
8. Fuster V. and Lewis A., Conner memorial lecture: mechanisms leading to myocardial infarction:insights from studies of vascular biology. Circulation 90: 2126-2146, 1994.
9. Dobrovolsky A.B. and Titaeva E.V., The fibronolysis system: regulation of activity and physiologic functions of its main components. Biochemistry (Mosc) 67: 99-108, 2002.
10. Spronk H.M., Govers-Riemslag J.W. and ten Cate H., The blood coagulation system as a molecular machine. Bioessays 25: 1220-1228, 2003.
11. Levi M., Keller T.T., van Gorp E. and ten Cate H., Infection and inflammation and the coagulation system. Cardiovasc. Res. 60: 26-39, 2003.
12. Eitzman D.T., Westrick R.J., Xu Z., Tyson J. and Ginsburg D., Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vas. Biol. 20: 1831-1834, 2000.
13. Sato K., Balla J., Otterbein L., Smith R.N., Brouard S., Lin Y., Csizmadia E., Sevigny J., Robson S.C., Vercellotti G., Choi A.M., Bach F.H. and Soares M.P., Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol. 166: 4185-4194, 2001.
14. Fujita T., Toda K., Karimova A., Yan S.F., Naka Y., Yet S.F. and Pinsky D.J., Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat. Med. 7: 598-604, 2001.
15. Farrehi P.M., Ozaki K., Carmeliet P. and Fay W.P., Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 97: 1002-1008, 1998.
16. Konstantinides S., Schäfer K., Thinnes T. and Loskutoff D.J., Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation 103: 576-583, 2001.
17. Schäfer K., Müller K., Hecke A., Mounier E., Goebel J., Loskutoff D.J. and Konstantinides S., Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscler. Thromb. Vas. Biol. 23: 2097-2103, 2003.
18. Otterbein L.E., Zuckerbraun B.S., Haga M., Liu F., Song R., Usheva A., Stachulak C., Bodyak N., Smith R.N., Csizmadia E., Tyagi S., Akamatsu Y., Flavell R.J., Billiar T.R., Tzeng E., Bach F.H., Choi A.M. and Soares M.P., Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat. Med. 9: 183-190, 2003.
19. Tulis D.A., Durante W., Liu X., Evans A.J., Peyton K.J. and Schafer A.I., Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104: 2710-2715, 2001.
20. Lindenblatt N., Bordel R., Schareck W., Menger M.D. and Vollmar B., Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler. Thromb. Vas. Biol. 24: 106, 2004.
21. Hamsten A., DeFaire U., Walldius G., Dahlen G., Szamois A., Landou C., Blomback M. and Wiman B., Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2: 3-9, 1987.
22. Strauss B.H., Lau H.K., Bowman K.A., Sparkes J., Chisholm R.J., Garvey M.B., Fenkell L.L., Natarajan M.K., Singh I. and Teitel J.M., Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 100: 1616-1622, 1999.
23. Thogersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., Huhtasaari F. and Hallmans G., High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women:evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98: 2241-2247, 1998.
24. Schneiderman J., Sawdey M.S., Keeton M.R., Bordin G.M., Bernstein E.F., Dilley R.B. and Loskutoff D.J., Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 89: 6998-7002, 1992.
25. Kauhanen P., Siren V., Carpen O., Vaheri A., Lepantalo M. and Lassila R., Plasminogen activator inhibitor-1 in neointima of vein grafts:its role in reduced fibrinolytic potential and graft failure. Circulation 96: 1783-1789, 1997.
26. Hasenstab D., Forough R. and Clowes A.W., Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats. Circ. Res. 80: 490-496, 1997.
27. Carmeliet P., Moons L., Lijnen R., Janssens S., Lupu F., Collen D. and Gerard R.D., Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 96: 3180-3191, 1997.
28. Hasenstab D., Lea H. and Clowes A.W., Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening. Arterioscler. Thromb. Vas. Biol. 20: 853-859, 2000.
29. Zhu Y., Farrehi P.M. and Fay W.P., Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice. Circulation 103: 3105-3110, 2001.
30. Degan J.L., Hemostatic factors and inflammatory disease. Thromb. Haemost. 82: 858-864, 1999.